Cargando…
Enumeration And Characterization Of Circulating Tumor Cells And Its Application In Advanced Gastric Cancer
BACKGROUND: Advanced gastric cancer (aGC) has a high global incidence and a high mortality rate and because of its high malignancy and heterogeneity, the existing methods for prognosis are limited, and a new treatment model is necessary. Circulating tumor cells (CTCs) could be considered as a “liqui...
Autores principales: | Cheng, Boran, Tong, Gangling, Wu, Xuan, Cai, Wenwu, Li, Zhu, Tong, Zhongyi, He, Lirui, Yu, Shaokang, Wang, Shubin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768312/ https://www.ncbi.nlm.nih.gov/pubmed/31576146 http://dx.doi.org/10.2147/OTT.S223222 |
Ejemplares similares
-
Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation
por: Wu, Xuan, et al.
Publicado: (2023) -
Efficacy of Olanzapine-Triple Antiemetic Regimen in Patients with Gastrointestinal Tumor and High Risk of Chemotherapy-Induced Nausea and Vomiting Receiving Moderately Emetogenic Chemotherapy: A Retrospective Study
por: Wu, Xuan, et al.
Publicado: (2020) -
MACC1 regulates PDL1 expression and tumor immunity through the c‐Met/AKT/mTOR pathway in gastric cancer cells
por: Tong, Gangling, et al.
Publicado: (2019) -
Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study
por: Tong, Gangling, et al.
Publicado: (2020) -
Intratumoral CD8(+) T cells as a potential positive predictor of chemoimmunotherapy response in PD-L1-negative advanced gastric cancer patients: a retrospective cohort study
por: Tong, Gangling, et al.
Publicado: (2022)